Literature DB >> 15639335

Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors.

Sophie North1, Michel Moenner, Andreas Bikfalvi.   

Abstract

Angiogenesis in tumors is controlled by the so-called 'angiogenic switch' which allows the passage from low invasive and poorly vascularized tumors to highly invasive and angiogenic tumors. A number of cellular stress factors such as hypoxia, nutrient deprivation or inducers of reactive oxygen species (ROS) are important stimuli of angiogenic signalling. The HIF system plays a significant role in several of these effects and the molecular mechanisms of its regulation have recently been characterized. In addition, HIF-independent mechanisms have been described which involved number of other molecules and transcription factors such as nuclear factor-(kappa)B (NF-(kappa)B) and p53. p53 is an important intracellular mediator of the stress response and is now also recognized as a modifier of the angiogenic response. p53 may interact with the HIF system but may also have direct effects on angiogenesis regulators or interfere with translation mechanisms of angiogenesis factors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15639335     DOI: 10.1016/j.canlet.2004.08.007

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  36 in total

1.  Cyr61 silencing reduces vascularization and dissemination of osteosarcoma tumors.

Authors:  N Habel; M Vilalta; O Bawa; P Opolon; J Blanco; O Fromigué
Journal:  Oncogene       Date:  2014-07-28       Impact factor: 9.867

2.  Heterogeneity of vascular and progenitor cell compartments in tumours from MMTV-PyVmT transgenic mice during mammary cancer progression.

Authors:  Mackenzie J Smith; Robert W Berger; Kanwal Minhas; Roger A Moorehead; Brenda L Coomber
Journal:  Int J Exp Pathol       Date:  2010-11-08       Impact factor: 1.925

3.  Rapid detection of hypoxia-inducible factor-1-active tumours: pretargeted imaging with a protein degrading in a mechanism similar to hypoxia-inducible factor-1alpha.

Authors:  Masashi Ueda; Takashi Kudo; Yuji Kuge; Takahiro Mukai; Shotaro Tanaka; Hiroaki Konishi; Azusa Miyano; Masahiro Ono; Shinae Kizaka-Kondoh; Masahiro Hiraoka; Hideo Saji
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04-29       Impact factor: 9.236

Review 4.  Anti-tumor activities of matrine and oxymatrine: literature review.

Authors:  Yan Liu; Yang Xu; Weidan Ji; Xiaoya Li; Bin Sun; Quangen Gao; Changqing Su
Journal:  Tumour Biol       Date:  2014-02-14

5.  Tumor dormancy due to failure of angiogenesis: role of the microenvironment.

Authors:  George N Naumov; Judah Folkman; Oddbjorn Straume
Journal:  Clin Exp Metastasis       Date:  2008-06-18       Impact factor: 5.150

6.  Kaposi's sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1.

Authors:  Feng-Chun Ye; David J Blackbourn; Michael Mengel; Jian-Ping Xie; Li-Wu Qian; Whitney Greene; I-Tien Yeh; David Graham; Shou-Jiang Gao
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

Review 7.  Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.

Authors:  Virginia Hernandez-Gea; Sara Toffanin; Scott L Friedman; Josep M Llovet
Journal:  Gastroenterology       Date:  2013-01-09       Impact factor: 22.682

Review 8.  Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy.

Authors:  Masuko Ushio-Fukai; Yoshimasa Nakamura
Journal:  Cancer Lett       Date:  2008-04-10       Impact factor: 8.679

9.  Superoxide dismutase is regulated by LAMMER kinase in Drosophila and human cells.

Authors:  Brian P James; William D Staatz; Sarah T Wilkinson; Emmanuelle Meuillet; Garth Powis
Journal:  Free Radic Biol Med       Date:  2008-12-24       Impact factor: 7.376

10.  Oxidative stress in NPC1 deficient cells: protective effect of allopregnanolone.

Authors:  Stefania Zampieri; Synthia H Mellon; Terry D Butters; Marco Nevyjel; Douglas F Covey; Bruno Bembi; Andrea Dardis
Journal:  J Cell Mol Med       Date:  2008-09-04       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.